Authors: Balemans, W Ebeling, M Patel, N Van Hul, E Olson, P Dioszegi, M Lacza, C Wuyts, W Van den Ende, J Willems, P Paes-Alves, AF Hill, S Bueno, M Ramos, FJ Tacconi, P Dikkers, FG Stratakis, C Lindpaintner, K Vickery, B Foernzler, D Van Hul, W

Citation: W. Balemans et al., Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST), HUM MOL GEN, 10(5), 2001, pp. 537-543

Authors: Roberts, JR Reigart, JR Ebeling, M Hulsey, TC

Citation: Jr. Roberts et al., Time required for blood lead levels to decline in nonchelated children, J TOX-CLIN, 39(2), 2001, pp. 153-160

Authors: Asadullah, K Friedrich, M Hanneken, S Rohrbach, C Audring, H Vergopoulos, A Ebeling, M Docke, WD Volk, HD Sterry, W

Citation: K. Asadullah et al., Effects of systemic interleukin-10 therapy on psoriatic skin lesions: Histologic, immunohistologic, and molecular biology findings, J INVES DER, 116(5), 2001, pp. 721-727

Authors: Asadullah, K Docke, WD Sabat, R Ebeling, M Volk, HD Sterry, W

Citation: K. Asadullah et al., Interleukin-10 in dermatology, HAUTARZT, 50(1), 1999, pp. 12-19

Authors: Asadullah, K Docke, WD Ebeling, M Friedrich, M Belbe, G Audring, H Volk, HD Sterry, W

Citation: K. Asadullah et al., Interleukin 10 treatment of psoriasis - Clinical results of a phase 2 trial, ARCH DERMAT, 135(2), 1999, pp. 187-192

Authors: Newman, RB Mauldin, JG Ebeling, M

Citation: Rb. Newman et al., Risk factors for neonatal death in twin gestations in the state of South Carolina, AM J OBST G, 180(3), 1999, pp. 757-762